✦ LIBER ✦

Southwest Oncology Group Study S0530: a phase 2 trial of clofarabine and cytarabine for relapsed or refractory acute lymphocytic leukaemia

✍ Scribed by Anjali S. Advani; Holly M. Gundacker; Olga Sala-Torra; Jerald P. Radich; Raymond Lai; Marilyn L. Slovak; Jeffrey E. Lancet; Steve E. Coutre; Robert K. Stuart; Martha P. Mims; Patrick J. Stiff; Frederick R. Appelbaum

Book ID: 108676973
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 70 KB
Volume: 151
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2010.08387.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

SWOG S0910: a phase 2 trial of clofarabi

SWOG S0910: a phase 2 trial of clofarabine/cytarabine/epratuzumab for relapsed/refractory acute lymphocytic leukaemia

✍ Advani, Anjali S.; McDonough, Shannon; Coutre, Steven; Wood, Brent; Radich, Jera 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

Phase I/II trial of clofarabine and cyta

Phase I/II trial of clofarabine and cytarabine in children with relapsed/refractory acute lymphoblastic leukemia (AAML0523): A report from the Children's Oncology Group

✍ Cooper, Todd M.; Razzouk, Bassem I.; Gerbing, Robert; Alonzo, Todd A.; Adlard, K 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 248 KB

A Phase 2 study of bortezomib combined w

A Phase 2 study of bortezomib combined with either idarubicin/cytarabine or cytarabine/etoposide in children with relapsed, refractory or secondary acute myeloid leukemia: A report from the Children's Oncology Group

✍ Horton, Terzah M.; Perentesis, John P.; Gamis, Alan S.; Alonzo, Todd A.; Gerbing 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB

A pediatric phase 1 trial of vorinostat

A pediatric phase 1 trial of vorinostat and temozolomide in relapsed or refractory primary brain or spinal cord tumors: A children's oncology group phase 1 consortium study

✍ Hummel, Trent R.; Wagner, Lars; Ahern, Charlotte; Fouladi, Maryam; Reid, Joel M. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB

Bendamustine Combined With Rituximab in

Bendamustine Combined With Rituximab in Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leukemia Study Group

✍ Fischer, K.; Cramer, P.; Busch, R.; Stilgenbauer, S.; Bahlo, J.; Schweighofer, C 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 141 KB

Combined bendamustine, prednisolone and

Combined bendamustine, prednisolone and thalidomide for refractory or relapsed multiple myeloma after autologous stem-cell transplantation or conventional chemotherapy: results of a Phase I clinical trial

✍ Wolfram Pönisch; Marta Rozanski; Hartmut Goldschmidt; Franz Albert Hoffmann; Tho 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB